Inside ibogaine.nz: the monitoring app changing aftercare
How the ibogaine.nz companion app extends clinical-grade cardiac and wellbeing monitoring into the recovery window — and why that window is where outcomes are decided.
The most dangerous days of ibogaine treatment are not always the session itself — they are the days after, when patients leave the clinic and cardiac effects can persist while clinical oversight drops away. The ibogaine.nz monitoring companion was built specifically for that gap.
Developed alongside New Zealand's prescription pathway, the app pairs with the patient during the recovery window and streams resting ECG snapshots, heart rate, and wellbeing check-ins to their care team.
What the app actually monitors
Cardiac: scheduled resting ECG and heart-rate capture, with trend views that flag QT-related concerns to the supervising clinician between visits.
Wellbeing: structured daily check-ins covering sleep, mood, cravings, and medication adherence — the leading indicators of relapse risk that are otherwise invisible until a follow-up call.
Escalation: when readings or check-ins cross configured thresholds, the care team is alerted and can intervene early, whether the patient is in Auckland or back home in Miami.
Why it matters for treatment outcomes
Every serious adverse event review in the ibogaine literature points to the same lesson: continuous oversight saves lives, and its absence is the common thread in preventable harm. Extending that oversight past discharge is the single highest-leverage improvement available to modern ibogaine care.
You can explore the app and its clinical model at ibogaine.nz. As always, this article is informational only and not medical advice.
This article is for informational purposes only and is not medical or legal advice. Ibogaine is an investigational substance with serious medical risks. Consult a licensed physician before considering any protocol.